PSG9 Activators
PSG9 Activators are comprised of a diverse array of chemical compounds that indirectly enhance the functional activity of PSG9 through modulation of various signaling pathways. Forskolin and 8-Br-cAMP, through their actions on adenylate cyclase and PKA, respectively, lead to increased intracellular cAMP levels, indirectly facilitating PSG9 activity by enhancing phosphorylation processes that are linked to PSG9 function. Similarly, by manipulating protein kinase C (PKC) activity, both Phorbol 12-myristate 13-acetate (PMA) and Bisindolylmaleimide I, through activation and inhibition respectively, modulate signaling pathways that are likely to result in the phosphorylation of proteins within the PSG9 pathway, thus indirectly upregulating PSG9 activity. Compounds that alter calcium signaling, such as Ionomycin and A23187, raise intracellular Ca2+ levels, potentially triggering calcium-dependent signaling cascades that contribute to PSG9 activation.
Additionally, LY294002 and Wortmannin, as PI3K inhibitors, could shift cellular signaling dynamics to favor PSG9 activation by attenuating the PI3K/AKT pathway, which, when overactive, may negatively regulate pathways PSG9 is involved in. U0126 and SB203580, which inhibit MEK and p38 MAPK respectively, may also indirectly enhance PSG9 activity by relaxing the suppression of alternative signaling routes that activate PSG9. The kinase inhibition mechanism of Epigallocatechin gallate (EGCG) and Genistein adds another layer, as they may potentiate PSG9 activity by reducing kinase-mediated competitive signaling, thereby indirectlypromoting PSG9-related pathways. Collectively, these PSG9 Activators, through targeted biochemical mechanisms, facilitate the enhancement of PSG9-mediated functions without the need for increasing its expression or direct stimulation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylate cyclase activator, which increases intracellular cAMP levels. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate various proteins, potentially leading to the activation of PSG9 through cAMP-responsive pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to the phosphorylation of target proteins, possibly enhancing the functional activity of PSG9 by modulating signaling pathways that PSG9 is part of. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a specific PKC inhibitor that can increase the activity of PSG9 by inhibiting PKC, thereby reducing negative feedback on pathways that PSG9 is involved in, leading to its functional upregulation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. By activating PKA, it can enhance the activity of PSG9 by promoting phosphorylation events within pathways PSG9 is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular Ca2+ levels, thereby potentially activating calcium-dependent proteins and signaling pathways that could enhance the activity of PSG9. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain kinases. Inhibition of these kinases might reduce competitive signaling pathways, thereby potentiating pathways that activate PSG9. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can alter AKT signaling. By inhibiting this pathway, LY294002 may shift the balance towards signaling pathways that activate PSG9. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a specific inhibitor of p38 MAPK. By inhibiting p38, it could shift cellular signaling towards pathways that activate PSG9. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore, similar to Ionomycin, and it can increase intracellular calcium levels, potentially enhancing the activity of PSG9 through calcium-dependent signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor, which may enhance PSG9 activity by inhibiting competitive signaling pathways, thereby indirectly activating PSG9-related signaling. | ||||||